{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T21:21:03Z","timestamp":1765401663522,"version":"3.46.0"},"reference-count":3,"publisher":"BMJ","issue":"6235","license":[{"start":{"date-parts":[[1980,7,26]],"date-time":"1980-07-26T00:00:00Z","timestamp":333417600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br Med J"],"published-print":{"date-parts":[[1980,7,26]]},"DOI":"10.1136\/bmj.281.6235.275-a","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T18:32:30Z","timestamp":1238697150000},"page":"275.2-276","source":"Crossref","is-referenced-by-count":16,"title":["Low bioavailability as a cause of apparent failure of dihydroergotamine in orthostatic hypotension."],"prefix":"10.1136","volume":"281","author":[{"given":"I N","family":"Olver","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G L","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Bobik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Esler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1980,7,26]]},"reference":[{"key":"ref_1","first-page":"106","article-title":"Comparative pharmacokinetic investigations with tritium-labelled ergot alkaloids after oral and intravenous administration in man","volume":"15","author":"Aellig, W.H.; Nuesch, E.","year":"1977","unstructured":"Aellig WH, Nuesch E. Comparative pharmacokinetic investigations with tritium-labelled ergot alkaloids after oral and intravenous administration in man. Int J Clin Pharmacol 1977;15:106-12.","journal-title":"Int J Clin Pharmacol"},{"key":"ref_2","first-page":"730","article-title":"Pharmaceutical Society of Great Britain. British pharmaceutical codex","year":"1973","unstructured":"Pharmaceutical Society of Great Britain. British pharmaceutical codex. London: Pharmaceutical Press, 1973:730-1."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/BF01937784","article-title":"9,10 Dihydroergotamine: production of antibodies and radioimmunoassay","volume":"32","author":"Rosenthaler, J.; Murger, H.","year":"1976","unstructured":"Rosenthaler J, Murger H. 9,10 Dihydroergotamine: production of antibodies and radioimmunoassay. Experientia 1976;32:234-6.","journal-title":"Experientia"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.281.6235.275-a","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.281.6235.275-a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T21:16:21Z","timestamp":1765401381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.281.6235.275-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1980,7,26]]},"references-count":3,"journal-issue":{"issue":"6235","published-online":{"date-parts":[[1980,7,26]]},"published-print":{"date-parts":[[1980,7,26]]}},"alternative-id":["10.1136\/bmj.281.6235.275-a"],"URL":"https:\/\/doi.org\/10.1136\/bmj.281.6235.275-a","relation":{},"ISSN":["0007-1447","1468-5833"],"issn-type":[{"type":"print","value":"0007-1447"},{"type":"electronic","value":"1468-5833"}],"subject":[],"published":{"date-parts":[[1980,7,26]]}}}